Keyphrases
Aberrations
16%
Anti-apoptotic
16%
Anti-glioma
16%
Apoptosis Resistance
16%
Biochemical Studies
16%
Cell Culture Model
16%
Dismal Prognosis
16%
Drug Development
33%
Effector Caspases
16%
Extreme Resistance
16%
Failure Rate
16%
Gefitinib
16%
Genetic Engineering
16%
Glioblastoma
100%
Glioblastoma multiforme
16%
Glioma
33%
Glioma Therapy
16%
Gold Nanoparticles(AuNPs)
16%
Human Disease
16%
Human Model
16%
Malignant Glioma
100%
Mode of Action
16%
Molecular Determinants
16%
Murine Model
16%
Nanomaterials
16%
Nanotechnological Platforms
16%
Neuro-oncology
16%
Novel Therapeutic Targets
16%
Oligonucleotides
16%
Oncogene
16%
Physiologically Relevant
16%
Preclinical Validation
16%
Refractoriness
16%
Small Interfering RNA (siRNA)
16%
Spherical nucleic Acids
16%
Surveillance Program
16%
Targeted Therapy
16%
Therapeutic Modalities
16%
Therapeutic Strategies
16%
Therapy Resistance
16%
Tumor Maintenance
16%
Tumor Progression
33%
Tumor Surveillance
16%
Unmet Needs
16%
Biochemistry, Genetics and Molecular Biology
Allele
50%
Animal Models
50%
Caspase
50%
Cell Culture
50%
Drive
50%
Gefitinib
50%
Mouse
50%
Murine
50%
Nucleic Acid
50%
Oligonucleotide
50%
Oncogene
50%
P53
50%
Small Interfering RNA
50%
Tumor Progression
100%
Upregulation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antiapoptotic
11%
Cell Culture
11%
Disease
22%
Drug Development
22%
Effector Caspase
11%
Gefitinib
11%
Glioblastoma
100%
Gold Nanoparticle
11%
Gold Nanoparticles
11%
Mouse
11%
Murine
11%
Nanomaterial
11%
Neoplasm
11%
Nucleic Acid
11%
Oligonucleotide
11%
Protein P53
11%
Small Interfering RNA
11%
Therapy Resistance
11%
Tumor Growth
22%